• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺细针抽吸术在封锁前、封锁期间和封锁后的趋势:我们从 COVID-19 大流行中学到了什么。

Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic.

机构信息

Department of Public Health, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

出版信息

Endocrine. 2021 Jan;71(1):20-25. doi: 10.1007/s12020-020-02559-z. Epub 2020 Dec 7.

DOI:10.1007/s12020-020-02559-z
PMID:33284396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7719849/
Abstract

PURPOSE

Nowadays, the clinical management of thyroid nodules needs to be multi-disciplinary. In particular, the crosstalk between endocrinologists and cytopathologists is key. When FNAs are properly requested by endocrinologists for nodules characterised by relevant clinical and ultrasound features, cytopathologists play a pivotal role in the diagnostic work-up. Conversely, improper FNA requests can lead to questionable diagnostic efficiency. Recently, recommendations to delay all non-urgent diagnostic procedures, such as thyroid FNAs, to contain the spread of COVID-19 infection, have made the interplay between endocrinologists and cytopathologists even more essential. The objective of this study was to assess the impact of COVID-19 pandemic on our practice by evaluating the total number of FNAs performed and the distribution of the Bethesda Categories before, during, and after the lockdown.

METHODS

We analysed the FNA trends before (1st January 2019 to March 13th 2020), during (March 14th to May 15th), and after (May 16th to July 7th) the lockdown.

RESULTS

Although the total number of weekly FNAs dropped from 62.1 to 23.1, our referring endocrinologists managed to prioritise patients with high-risk nodules. In fact, in the post-lockdown, the weekly proportion of benign diagnoses dropped on average by 12% and that of high-risk diagnoses increased by 6%.

CONCLUSIONS

The lesson we have learned so far from this pandemic is that by applying safety protocols to avoid contagion and by increasing the threshold for FNA requests for thyroid nodules, we can continue to guarantee our services to high-risk patients even in times of a health crisis.

摘要

目的

如今,甲状腺结节的临床管理需要多学科参与。特别是内分泌学家和细胞病理学家之间的交流至关重要。当内分泌学家根据具有相关临床和超声特征的结节恰当地请求进行细针穿刺抽吸活检(FNAs)时,细胞病理学家在诊断工作中起着关键作用。相反,不适当的 FNA 请求可能导致诊断效率受到质疑。最近,为了控制 COVID-19 感染的传播,建议延迟所有非紧急的诊断程序,如甲状腺 FNAs,这使得内分泌学家和细胞病理学家之间的相互作用更加重要。本研究的目的是通过评估封锁前后进行的 FNAs 总数和 Bethesda 分类分布,评估 COVID-19 大流行对我们实践的影响。

方法

我们分析了封锁前(2019 年 1 月 1 日至 2020 年 3 月 13 日)、封锁期间(2020 年 3 月 14 日至 5 月 15 日)和封锁后(2020 年 5 月 16 日至 7 月 7 日)的 FNA 趋势。

结果

尽管每周 FNAs 的总数从 62.1 例降至 23.1 例,但我们的转诊内分泌学家成功地为高风险结节患者提供了优先治疗。事实上,在封锁后,每周良性诊断的比例平均下降了 12%,高风险诊断的比例增加了 6%。

结论

我们从这场大流行中学到的教训是,通过应用安全协议来避免传染,并提高对甲状腺结节进行 FNA 请求的门槛,我们即使在卫生危机时期也可以继续为高危患者提供服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d238/7835294/d4590783599d/12020_2020_2559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d238/7835294/37f4e728a739/12020_2020_2559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d238/7835294/d4590783599d/12020_2020_2559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d238/7835294/37f4e728a739/12020_2020_2559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d238/7835294/d4590783599d/12020_2020_2559_Fig2_HTML.jpg

相似文献

1
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic.甲状腺细针抽吸术在封锁前、封锁期间和封锁后的趋势:我们从 COVID-19 大流行中学到了什么。
Endocrine. 2021 Jan;71(1):20-25. doi: 10.1007/s12020-020-02559-z. Epub 2020 Dec 7.
2
A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.2015 年甲状腺结节管理临床实践模式调查。
J Clin Endocrinol Metab. 2016 Jul;101(7):2853-62. doi: 10.1210/jc.2016-1155. Epub 2016 Mar 25.
3
Variation in the Quality of Thyroid Nodule Evaluations Before Surgical Referral.甲状腺结节术前评估质量的差异。
J Surg Res. 2019 Dec;244:9-14. doi: 10.1016/j.jss.2019.06.024. Epub 2019 Jul 3.
4
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases.细胞病理学家能够可靠地进行超声引导下甲状腺细针穿刺活检:对连续3715例病例进行的为期一年的审计。
Cytopathology. 2016 Apr;27(2):115-21. doi: 10.1111/cyt.12243. Epub 2015 Mar 21.
5
Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS)评分较高是否预示恶性风险增加?评估甲状腺结节时 ACR TI-RADS 与细针穿刺细胞学的相关性研究。
Cancer Cytopathol. 2020 Jul;128(7):470-481. doi: 10.1002/cncy.22254. Epub 2020 Feb 20.
6
Non-diagnostic thyroid nodules after application of the Bethesda system: a study evaluating the interval for repeat aspiration for non-diagnostic results.应用贝塞斯达系统后非诊断性甲状腺结节:一项评估非诊断性结果重复穿刺间隔时间的研究
Acta Radiol. 2018 Mar;59(3):305-312. doi: 10.1177/0284185117715286. Epub 2017 Jun 7.
7
Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.初次细针穿刺活检未明确诊断后,甲状腺结节重复细针穿刺活检的最佳时机。
Am J Surg. 2017 Feb;213(2):433-437. doi: 10.1016/j.amjsurg.2016.04.010. Epub 2016 Jun 14.
8
Core-Needle Biopsy Does Not Show Superior Diagnostic Performance to Fine-Needle Aspiration for Diagnosing Thyroid Nodules.Core-Needle 活检在诊断甲状腺结节方面并不优于细针抽吸诊断。
Yonsei Med J. 2020 Feb;61(2):161-168. doi: 10.3349/ymj.2020.61.2.161.
9
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.评价 BRAF、RAS、RET/PTC 和 PAX8/PPARγ 改变在不同 Bethesda 诊断分类中的情况:在意大利南部不同医院的 1172 例甲状腺细针抽吸活检标本中进行的 7 基因 panel 检测的有效性的多中心前瞻性研究。
Cancer Cytopathol. 2020 Feb;128(2):107-118. doi: 10.1002/cncy.22217. Epub 2019 Dec 10.
10
Fine needle aspiration of the thyroid: a contemporary experience of 3981 cases.甲状腺细针抽吸术:3981 例当代经验。
J Surg Res. 2011 Sep;170(1):48-51. doi: 10.1016/j.jss.2011.02.048. Epub 2011 Apr 9.

引用本文的文献

1
Nationwide trends and the impact of an oncology hospital network on reducing the burden of thyroid cytology procedures.全国范围内的趋势以及肿瘤医院网络对减轻甲状腺细胞学检查负担的影响。
Int J Cancer. 2025 Sep 15;157(6):1120-1129. doi: 10.1002/ijc.35462. Epub 2025 May 2.
2
Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery.COVID-19 大流行对甲状腺癌手术的影响。
Curr Oncol. 2024 Jun 19;31(6):3579-3590. doi: 10.3390/curroncol31060263.
3
Impact of COVID-19 pandemic on thyroidectomy for malignant diseases in high-volume referral centers.

本文引用的文献

1
Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea, Iran and Italy.新冠肺炎疫情流行期间的甲状腺手术:中国、韩国、伊朗和意大利的经验教训。
J Endocrinol Invest. 2021 May;44(5):1065-1073. doi: 10.1007/s40618-020-01407-1. Epub 2020 Sep 2.
2
Thyroid cancer in the age of COVID-19.新冠疫情时代的甲状腺癌。
Endocr Relat Cancer. 2020 Nov;27(11):R407-R416. doi: 10.1530/ERC-20-0279.
3
Excess Deaths and Hospital Admissions for COVID-19 Due to a Late Implementation of the Lockdown in Italy.
COVID-19 大流行对高容量转诊中心恶性疾病甲状腺切除术的影响。
Updates Surg. 2024 Jun;76(3):1073-1083. doi: 10.1007/s13304-024-01771-0. Epub 2024 Feb 13.
4
The effect of COVID-19 pandemic restrictions on the management of differentiated thyroid cancer in Turkey: a single tertiary centre experience.COVID-19 大流行限制措施对土耳其分化型甲状腺癌管理的影响:单中心经验。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2587-2595. doi: 10.1007/s00405-024-08496-1. Epub 2024 Feb 13.
5
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned.CT 引导下经皮肺穿刺活检细胞学检查在 COVID-19 大流行期间用于肺癌诊断:我们的经验教训。
Tomography. 2023 Mar 31;9(2):759-767. doi: 10.3390/tomography9020061.
6
Thyroid surgery during the COVID-19 pandemic: difficulties - how to improve.2019冠状病毒病大流行期间的甲状腺手术:困难——如何改善
Innov Surg Sci. 2022 Oct 11;7(3-4):125-132. doi: 10.1515/iss-2022-0015. eCollection 2022 Dec.
7
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study.COVID-19 大流行对封锁后时期细胞病理学实践的影响:一项国际多中心研究。
Cancer Cytopathol. 2022 May;130(5):344-351. doi: 10.1002/cncy.22547. Epub 2022 Jan 10.
8
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):在各种甲状腺疾病发病机制中的新作用
J Inflamm Res. 2021 Nov 24;14:6191-6221. doi: 10.2147/JIR.S332705. eCollection 2021.
9
Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution.探索新冠病毒与甲状腺癌的未知关联,聚焦分化型甲状腺癌:呼吁谨慎对待
Cancers (Basel). 2021 Nov 18;13(22):5785. doi: 10.3390/cancers13225785.
10
Cytopathology practice during the COVID-19 postlockdown: An Italian experience.新冠疫情封锁后的细胞病理学实践:意大利经验。
Cancer Cytopathol. 2021 Jul;129(7):548-554. doi: 10.1002/cncy.22416. Epub 2021 Feb 17.
意大利封锁措施实施较晚导致的 COVID-19 超额死亡和住院人数。
Int J Environ Res Public Health. 2020 Aug 5;17(16):5644. doi: 10.3390/ijerph17165644.
4
Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines.甲状腺结节的恶性风险分层和 FNA 建议:ACR TI-RADS、AACE/ACE/AME 和 ATA 指南的比较。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102625. doi: 10.1016/j.amjoto.2020.102625. Epub 2020 Jun 24.
5
Measures to reduce diagnostic error and improve clinical decision making in thyroid FNA aspiration cytology: A proposed framework.降低甲状腺细针抽吸细胞学诊断错误和改善临床决策的措施:一个建议的框架。
Cancer Cytopathol. 2020 Dec;128(12):917-927. doi: 10.1002/cncy.22309. Epub 2020 Jun 16.
6
Thyroid cytology in the times of coronavirus.新冠疫情时代的甲状腺细胞学
Diagn Cytopathol. 2021 Apr;49(4):467-468. doi: 10.1002/dc.24510. Epub 2020 Jun 1.
7
Thyroid FNA in the time of coronavirus: The interventional cytopathologist point of view.新冠疫情期间的甲状腺细针穿刺活检:介入细胞病理学家的观点
Cancer Cytopathol. 2020 Aug;128(8):589. doi: 10.1002/cncy.22294. Epub 2020 May 28.
8
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer.COVID-19 时期的内分泌学:甲状腺结节和癌症的治疗。
Eur J Endocrinol. 2020 Jul;183(1):G41-G48. doi: 10.1530/EJE-20-0269.
9
Cytology in the time of coronavirus disease (COVID-19): an Italian perspective.冠状病毒病(COVID-19)时期的细胞学:意大利的观点。
J Clin Pathol. 2021 Apr;74(4):261-263. doi: 10.1136/jclinpath-2020-206614. Epub 2020 Apr 20.
10
Thyroid FNA: Is cytopathologist review of ultrasound features useful?甲状腺细针穿刺抽吸活检:细胞病理学家对超声特征的评估是否有用?
Cancer Cytopathol. 2020 Aug;128(8):523-527. doi: 10.1002/cncy.22262. Epub 2020 Mar 10.